RecruitingNot ApplicableNCT07434726

In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta

CPReboa: In-hospital Cardiopulmonary Resuscitation With Balloon Occlusion of the Descending Aorta


Sponsor

Insel Gruppe AG, University Hospital Bern

Enrollment

98 participants

Start Date

Apr 14, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study will test if a sustained Return of Spontaneous Circulation (ROSC) in patients with cardiac arrest is more frequent when patients receive advanced cardiac life support (ACLS) alone or when they receive ACLS plus a balloon occlusion of the thoracic aorta.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Advanced Cardiac Life Support (ACLS) and a medical device called resuscitative endovascular occlusion of the aorta (REBOA) for people with cardiac arrest. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEresuscitative endovascular occlusion of the aorta (REBOA)

Insertion of a balloon catheter through the common femoral artery, retrograde advancement of the catheter into the descending thoracic aorta, ballon occlusion of the aorta

OTHERAdvanced Cardiac Life Support (ACLS)

Advanced Cardiac Life Support (ACLS) as per American Heart Association (AHA) or European Resuscitation Council (ERC) standards


Locations(1)

Inselspital University Hospital Bern

Bern, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07434726


Related Trials